ConductScience.org, home
DLD-1
API referenceFor AI assistants

Cell line · CVCL_0248

Papers217

1 to 20 of 217

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
PubMed 43000531Nat Commun2026Its Methods give the RRID and name the linePubMed
PubMed 42999633Immunotargets Ther2026Its Methods give the RRID and name the linePubMed
Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer.Elife2026Its Methods give the RRID and name the linePubMed
Hangeshashinto Induces Apoptosis and Suppresses Colorectal Cancer Growth In Vitro and In Vivo.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis.iScience2026Its Methods give the RRID and name the linePubMed
SLC35D1 Is Associated with Colorectal Cancer Progression, EMT-Related Phenotypes, and Immune Infiltration.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
O-GlcNAcylated TCF4 Drives Ferroptosis Resistance and Tumor-Associated Macrophage Infiltration to Promote Colorectal Cancer Liver Metastasis.Cancers (Basel)2026Its Methods give the RRID and name the linePubMed
Biological Activities and Phytochemical Composition of Arum rupicola var. rupicola: An In Vitro and In Silico Study.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Mutant KRAS-m6A Epitranscriptome Axis Promotes Colorectal Cancer and is a Therapeutic Target.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
ALDH2 regulates oxaliplatin sensitivity via PDE4B in p53-mutant colorectal cancer.Int J Med Sci2026Its Methods give the RRID and name the linePubMed
Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations in vitro and in vivo.Sci Adv2026Its Methods give the RRID and name the linePubMed
Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.Biomolecules2026Its Methods give the RRID and name the linePubMed
A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis.Cell Mol Life Sci2026Its Methods give the RRID and name the linePubMed
Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.Cell Rep Methods2026Its Methods give the RRID and name the linePubMed
PRKN mediates the ubiquitination of SCAF8 to reduce the mRNA stability of KLF5 and its transcriptional activation of EFNA3 in colorectal cancer.Cell Mol Biol Lett2026Its Methods give the RRID and name the linePubMed
Targeting colorectal cancer with pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides: comprehensive in vitro evaluation.Sci Rep2026Its Methods give the RRID and name the linePubMed
Druggable β-catenin palmitoyl-switch coordinates immune evasion via immunogenic ferroptosis resistance and PD-L1-mediated immunosuppression.Cell Rep Med2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0248/papers

API referenceFor AI assistants